CNE100002318
CNE100002318
SHANGHAI RUNDA MEDICAL TECHNOLO
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 62/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±53.1% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.5x).
Beta (Market Relation)
0.54x
DefensiveVolatility (5Y p.a.)
53.1% p.a.
5-Year HorizonMax Drawdown (5Y)
-66.5%
5-Year HorizonSharpe Ratio
-0.09
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -36.5% |
| 3 Years | 54.1% | -66.5% | -0.31 | -14.2% |
| 5 Years | 53.1% | -66.5% | -0.09 | -1.5% |
| 10 Years | 46.6% | -66.5% | -0.18 | -6% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (53.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -66.5% in the extended horizon.